Showing results (441-450 of 473) with videos related to

Sort By:
Pageof 48
Hereditary Cancer in Clinical Practice|September 27, 2021
Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guidelineMichelle Jacobson, Nadia Coakley, Marcus Bernardini, et al.
Hereditary Cancer in Clinical Practice|March 22, 2022
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumorAlicja Ogrodniczak, Janusz Menkiszak, Jacek Gronwald, et al.
Hereditary Cancer in Clinical Practice|April 14, 2022
Delineating the role of osteoprotegerin as a marker of breast cancer risk among women with a BRCA1 mutationSarah Sohyun Park, Aleksandra Uzelac, Joanne Kotsopoulos
Hereditary Cancer in Clinical Practice|April 16, 2022
CMMRD caused by PMS1 mutation in a sudanese consanguineous familyReem S Hamad, Muntaser E Ibrahim
Hereditary Cancer in Clinical Practice|October 28, 2021
Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini reviewA Daniele, R Divella, B Pilato, et al.
Hereditary Cancer in Clinical Practice|October 17, 2021
"Left in limbo": Exploring how patients with colorectal cancer interpret and respond to a suspected Lynch syndrome diagnosisNicole den Elzen, Sharelle L Joseland, Sibel Saya, et al.
Hereditary Cancer in Clinical Practice|September 15, 2018
Polyglobulia in patients with hemangioblastomas is related to tumor size but not to serum erythropoietinMarie T Krüger, Jan-Helge Klingler, Cordula Jilg, et al.
Hereditary Cancer in Clinical Practice|April 8, 2021
Massive parallel sequencing in a family with rectal cancerKarin Wallander, Jessada Thutkawkorapin, Ellika Sahlin, et al.
Hereditary Cancer in Clinical Practice|April 10, 2021
Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of adviceBettina Meiser, Rajneesh Kaur, April Morrow, et al.
Hereditary Cancer in Clinical Practice|June 29, 2012
Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family historyCarmen Radecki Breitkopf, Pamela S Sinicrope, Kari G Rabe, et al.
Pageof 48